I believe in care that is rooted in compassion, cultural sensitivity and a deep respect for each child or teen and their family. I value building trusting relationships with families that support ongoing collaboration, shared decision making and invaluable continuity of care.
About Harlori K. Bains, MD
Harlori K. Bains, MD, is director of pediatric neuroimmunology and a pediatric neurologist at Phoenix Children's. Dr. Bains is skilled in treating conditions such as pediatric-onset multiple sclerosis (MS), neuromyelitis optica, myelin oligodendrocyte glycoprotein (MOG) antibody disorder, acute disseminated encephalomyelitis (ADEM), acute flaccid myelitis, and autoimmune encephalitis.
Dr. Bains earned her bachelor's degree from Michigan State University in East Lansing, before graduating with her medical degree from Wayne State University School of Medicine in Detroit. She completed her medical training in Phoenix with a residency in pediatric neurology at Phoenix Children's and Maricopa Medical Center, serving as chief resident. In addition, she completed a fellowship in neuroimmunology at Barrow Neurological Institute.
Dr. Bains is a member of the Child Neurology Society and the Consortium of Multiple Sclerosis Centers. She was an invited presenter at the 2nd Annual Laura L. Sweetman Alumni Lectureship at Phoenix Children's in 2024 and has published research in the peer-reviewed publications including Neurology and mBio.
Spending time with her husband, their child and dogs brings Dr. Bains immense joy. Together they enjoy simple moments such as a family walk or venturing out to try a new restaurant.
Medical School / Education
Wayne State University School of Medicine, Detroit, MI
Residency
(Pediatric Neurology) Phoenix Children's / Maricopa Medical Center, Phoenix, AZ
Chief Resident
Fellowship
(Neuroimmunology) Barrow Neurological Institute, Phoenix, AZ
Neurology with Special Qualification in Child Neurology
American Board of Psychiatry & Neurology
Professional Affiliations
Member, Child Neurology Society
Member, Consortium of Multiple Sclerosis Centers
Bowers JR, Valentine M, Harrison V, Fofanov V, Gillece J, Delisle J, Patton B, Schupp J, Sheridan K, Lemmer D, Ostdiek S, Bains HK, Heim J, Sylvester T, Prasai S, Kretschmer M, Fowle N, Komatsu K, Brady S, Robinson S, Fitzpatrick K, Alsop E, Hutchins E, Jensen K, Keim P, Engelthaler DM. Genomic Analyses of Acute Flaccid Myelitis Cases Among a Potential Cluster in Arizona Provide Further Evidence of Enterovirus D68 Role. MBio. 2019; 10(1):e02262-18. Published 2019 Jan 22. DOI: 10.1128/mBio.02262-18.
Messacar K, Sillau S, Hopkins SE, Otten C, Wilson-Murphy M, Wong B, Santoro JD, Treister A, Bains HK, Torres A, Zabrocki L, Glanternik JR, Hurst AL, Martin JA, Schreiner T, Makhani N, DeBiasi RL, Kruer MC, Tremoulet AH, Van Haren K, Desai J, Benson LA, Gorman MP, Abzug MJ, Tyler KL, Dominguez SR. Safety, Tolerability and Efficacy of Fluoxetine as an Antiviral for Enterovirus D68-Associated Acute Flaccid Myelitis: A Multicenter Retrospective Cohort Study. Neurology Nov 2018,10.1212/WNL.0000000000006670; DOI:10.1212/WNL.0000000000006670.
Iverson SA, Ostdiek S, Prasai S, Engelthaler DM, Kretschmer M, Fowle N, Tokhie HK, Routh J, Sejvar J, Ayers T, Bowers J, Brady S, Rogers S, Nix A, Komatsu K, Sunenshine R, AFM Investigation Team. Notes from the Field: Cluster of Acute Flaccid Myelitis in Five Pediatric Patients - Maricopa County, Arizona, 2016. MMWR Morb Mortal Wkly Rep 2017;66:758-760. DOI: 10.15585/mmwr.mm6628a4.
